CareDx stock jumps on Medicare test payment clarity
news.google.com
CareDx shares rose nearly 40% after Medicare clarified payment limits for its transplant‑related test, indicating stronger revenue prospects for the company.
Continue reading at news.google.com →
Related Reading
- What ‘unsafe’ conditions led to closure of Delmar assisted living facility · news10.com · 25m ago
- MGB Health Plan removes Dana-Farber Cancer Institute from Medicare Advantage network · CBS News · 28m ago
- What conditions caused a Delmar assisted living facility to close? · news10.com · 35m ago
- Nursing Home Jobs Nearly Flat in August as Healthcare Hiring Slows · Skilled Nursing News · 55m ago
- As Special Needs Plans Surge, CMS Weighs Consolidating Plan Types Against Specialized Care in Nursing Homes · Skilled Nursing News · 55m ago
- MGB removes Dana-Farber Cancer Institute from Medicare Advantage network · CBS News · 1h ago
